Advertisement.

DBVT Projected Dividend Yield

Sponsored ADR (New)/DBV Technologies, Boulogne-Billancourt ( NASDAQ : DBVT )

DBV Technologies is a clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Viaskin™. Co.'s therapeutic approach is based on epicutaneous immunotherapy, or EPIT™, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin™. Co.'s lead product candidate, Viaskin™ Peanut, has completed a global Phase III program for the treatment of peanut-allergic patients four to 11 years of age. Co.'s second product candidate, Viaskin™ Milk, is in development for the treatment of cow's milk protein allergy children two to 17 years of age.

21 YEAR PERFORMANCE RESULTS

DBVT Dividend History Detail
DBVT Dividend News
DBVT Competitors News

# of Shares: 0

Closing Price: 3.36

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000